|||||
acute myeloïde leukemie en myelodysplastisch syndroom, gerelateerd aan alkylerend middel (aandoening)
acute myeloïde leukemie en myelodysplastisch syndroom, gerelateerd aan alkylerend middel
AML en myelodysplastisch syndroom, gerelateerd aan alkylerend agens
Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent
A subgroup of therapy-related myeloid neoplasms (t-MN), associated with a treatment of an unrelated neoplastic or autoimmune disease with cytotoxic agents, like cyclophosphamid, platins, melphalan and others. The neoplastic cells typically harbor unbalanced aberrations of chromosomes 5 and 7 (monosomy 5/del(5q) and monosomy 7/del(7q)) or a complex karyotype. It usually presents with multilineage dysplasia and cytopenias 5-10 years after exposure, with symptoms related to the degree of bone marrow failure and the corresponding cytopenia (fatigue, bleeding and bruising, recurrent infections, bone pain).
Id766045006
StatusDefined
referentieset met complexe 'mapping' naar ICD-10
TargetC92.8
RuleTRUE
AdviceALWAYS C92.8 | POSSIBLE REQUIREMENT FOR MORPHOLOGY CODE
CorrelationSNOMED CT source code to target map code correlation not specified
TargetD46.7
RuleTRUE
AdviceALWAYS D46.7 | POSSIBLE REQUIREMENT FOR MORPHOLOGY CODE
CorrelationSNOMED CT source code to target map code correlation not specified